Section Arrow
XENE.NASDAQ
- Xenon Pharmaceuticals
Quotes are at least 15-min delayed:2026/03/09 08:42 EDT
Pre Market
Last
 62.1
+20.17 (+48.10%)
Bid
62.01
Ask
62.17
High 65.75 
Low 44.9 
Volume 1.74M 
Regular Hours (Closed)
Last
 41.94
-0.1 (-0.24%)
Day High 
42.24 
Prev. Close
42.04 
1-M High
46.99 
Volume 
1.08M 
Bid
62.01
Ask
62.17
Day Low
41.05 
Open
41.81 
1-M Low
40.74 
Market Cap 
3.25B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 43.39 
20-SMA 42.69 
50-SMA 42.5 
52-W High 46.99 
52-W Low 26.74 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.89/-5.48
Enterprise Value
3.26B
Balance Sheet
Book Value Per Share
7.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DAWNDay One Biopharmaceuticals21.2+8.43+66.01%-- 
Pre Market 21.22 +0.01 +0.05%
IOVAIovance Biotherapeutics5.13+0.535+11.64%-- 
Pre Market 4.9997 -0.1353 -2.63%
QNCXQuince Therapeutics0.1023-0.0025-2.39%-- 
Pre Market 0.098 -0.0043 -4.20%
EDSAEdesa Biotech6.52+2.91+80.61%-- 
Pre Market 6.17 -0.36 -5.51%
IBRXImmunityBio8.67-0.2801-3.13%-- 
Pre Market 8.25 -0.4 -4.62%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.